Rachel Langland
- Co-authors
- Janet HeasmanH. Jeffrey LawrenceBrian RichardsonStuart HandwergerDaniel S. KesslerDouglas W. HoustonMatthew KofronGrantland Hillman
- Topics
- Melanoma and MAPK Pathways (6 papers)Computational Drug Discovery Methods (5 papers)Colorectal Cancer Treatments and Studies (4 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Rachel Langland
15 papers receiving 786 citations
Peers
Comparison fields: 5 of 72
- Molecular Biology 525
- Oncology 376
- Genetics 125
- Pathology and Forensic Medicine 123
- Cancer Research 116
Countries citing papers authored by Rachel Langland
This map shows the geographic impact of Rachel Langland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Langland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Langland more than expected).
Fields of papers citing papers by Rachel Langland
This network shows the impact of papers produced by Rachel Langland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Langland. The network helps show where Rachel Langland may publish in the future.
Co-authorship network of co-authors of Rachel Langland
This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Langland. A scholar is included among the top collaborators of Rachel Langland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Langland. Rachel Langland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 93 | |
| 3 | 38 | |
| 4 | 113 | |
| 5 | 117 | |
| 6 | 5 | |
| 7 | 1 | |
| 8 | 182 | |
| 9 | 2 | |
| 10 | Development of a companion diagnostic test for inhibitors of V600E BRAF | 2 |
| 11 | 92 | |
| 12 | 36 | |
| 13 | 67 | |
| 14 | 43 | |
| 15 | 6 |
About Rachel Langland
Rachel Langland is a scholar working on Computational Theory and Mathematics, Oncology and Molecular Biology, having authored 15 papers that have together received 805 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (6 papers), Computational Drug Discovery Methods (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). The work is most often cited by research in Oncology (376 citations), Cancer Research (116 citations) and Molecular Biology (525 citations). Rachel Langland has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Janet Heasman, H. Jeffrey Lawrence, Brian Richardson, Stuart Handwerger, Daniel S. Kessler, Douglas W. Houston, Matthew Kofron, Grantland Hillman, Lin Wu and Suzanne Cheng. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.